Anais brasileiros de dermatologia最新文献

{"title":"Merkel cell carcinoma coexisting with squamous cell carcinoma^⋆.","authors":"Mariana Abdo de Almeida, Neusa Yuriko Sakai Valente, Mariangela Cristina Crispino Barata, Emílio Martins Curcelli, Bruna Nascimento Arruda Scabello","doi":"10.1016/j.abd.2024.10.006","DOIUrl":"https://doi.org/10.1016/j.abd.2024.10.006","url":null,"abstract":"","PeriodicalId":7787,"journal":{"name":"Anais brasileiros de dermatologia","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143810307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Borderline lepromatous leprosy with lymph node infiltration: Dermatology helps helping to clarify challenging diagnoses.","authors":"Victor Henrique Murback Dos Reis, Anna Carolina Miola, Cesar Augusto Zago Ferreira, Simone de Pádua Milagres, Joel Carlos Lastória, Juliano Vilaverde Schmitt","doi":"10.1016/j.abd.2024.10.004","DOIUrl":"https://doi.org/10.1016/j.abd.2024.10.004","url":null,"abstract":"","PeriodicalId":7787,"journal":{"name":"Anais brasileiros de dermatologia","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143794458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hand dermatitis: a 6-year experience in a tertiary referral Brazilian hospital.","authors":"Larissa Relva da Fonte Gonçalves Endlich, Luciana Paula Samorano, Ricardo Spina Nunes, Vitor Manoel Silva Dos Reis","doi":"10.1016/j.abd.2024.08.010","DOIUrl":"https://doi.org/10.1016/j.abd.2024.08.010","url":null,"abstract":"<p><strong>Background: </strong>Hand dermatitis (HD) is a prevalent inflammatory skin disease with a significant socioeconomic impact.</p><p><strong>Objectives: </strong>To characterize the population of HD patients followed up at the Department of Dermatology of a tertiary hospital.</p><p><strong>Methods: </strong>A cross-sectional, retrospective and descriptive study was carried out through the analysis of medical records of HD patients assisted at the Allergy Clinic of the Department of Dermatology, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, between March 1, 2016 and August 31, 2022.</p><p><strong>Results: </strong>Of the 175 patients, 73.3% were women, and the mean age at the onset of the condition was 41.7 years. There was a statistically significant association between occupation categories and the presence of occupational dermatitis. Cases were classified as irritant contact dermatitis (49.7%), allergic contact dermatitis (57.1%) and endogenous vesicular HD (3.4%). It was observed a statistically significant higher frequency of patch tests positivity for methylchloroisothiazolinone and methylisothiazolinone (MCI/MI) and nickel sulfate in women and for potassium bichromate and carba mix in men. DLQI was assessed in 77 patients, and the average score was 7.8 points.</p><p><strong>Study limitations: </strong>As limitations, the authors point out data collection from medical records, which lacked some information. Furthermore, as this was a cross-sectional study, it was not possible to assess cause-and-effect relationships between the variables.</p><p><strong>Conclusions: </strong>The present data reinforces the importance of patch tests in HD investigation and highlights the high sensitivity rates to MCI/MI and nickel sulfate in Brazilian women and to potassium bichromate and carba mix in Brazilian men patients.</p>","PeriodicalId":7787,"journal":{"name":"Anais brasileiros de dermatologia","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143750734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Efficacy and safety of dupilumab in patients with moderate-to-severe bullous pemphigoid: a systematic review and meta-analysis.","authors":"Júlia Opolski Nunes da Silva, Rodrigo Ribeiro E Silva, Paulo Victor Zattar Ribeiro, Patrícia Silva Farah, Raquel Bissacotti Steglich","doi":"10.1016/j.abd.2024.08.008","DOIUrl":"https://doi.org/10.1016/j.abd.2024.08.008","url":null,"abstract":"<p><strong>Objective: </strong>Evaluate the safety and efficacy of dupilumab in treating moderate-to-severe bullous pemphigoid.</p><p><strong>Methods: </strong>The authors performed a systematic review and meta-analysis of comparative studies of Dupilumab combined with corticosteroids and conventional corticosteroid therapy alone in patients with moderate-to-severe bullous pemphigoid. PubMed, Embase and Cochrane databases were searched for studies published up to December 2023. Data were extracted from published reports and quality assessment was performed according to Cochrane recommendations.</p><p><strong>Results: </strong>A total of four studies involving 127 patients were included, of which 53 received Dupilumab combined with corticosteroids, while the other 74 were administered corticosteroids alone. Regarding efficacy, Dupilumab the time before new blister formation stopped (MD = -5.13 days; 95% CI -7.12 to -3.15; p < 0.0001) and demonstrated a greater reduction in Bullous Pemphigoid Disease Area Index (MD = -3.90; 95% CI -5.52 to -2.27; p < 0.0001) and Numeric Rating Scale for Pruritus (SMD = -1.37; 95% CI -2.02 to -0.72; p < 0.0001) compared with patients who received conventional therapy. However safety endpoints, adverse events (RR = 0.78; 95% CI 0.58 to 1.05; p = 0.10) and relapses (RR = 0.50; 95% CI 0.19 to 1.36; p = 0.17) showed no significance. The main limitations were retrospective studies with small samples and limited results in clinical practice and a moderate overall risk of bias.</p><p><strong>Conclusion: </strong>Compared with conventional therapy, Dupilumab decreased the time before new blister formation stopped in 5.13 days, as well as Disease Area Index and Pruritus, without interfering with adverse events and relapse.</p>","PeriodicalId":7787,"journal":{"name":"Anais brasileiros de dermatologia","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143750723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The real-world burden of atopic dermatitis: MEASURE-AD results from Brazil, Mexico, and Argentina.","authors":"Catalina Rincón Pérez, Valeria Aoki, Roberta F Criado, Martti Antila, Maria Valeria Angles, Tania Ferreira Cestari, Delfina Guadalupe Villanueva Quintero, Gabriel Magariños, Carla Castro, Adriana López Tello-Santillán, Magda Weber, Daniel Lorenzini, Caio Cesar Silva de Castro, Jorge Maspero, Linda García-Hidalgo, Limei Zhou, Shereen Hammad, Lucila de Campos, Tatiane Cristina Rodrigues, Carolina Arzelán, Paula C Luna","doi":"10.1016/j.abd.2024.05.011","DOIUrl":"https://doi.org/10.1016/j.abd.2024.05.011","url":null,"abstract":"<p><strong>Background: </strong>Atopic dermatitis (AD) burden increases with disease severity.</p><p><strong>Objective: </strong>Characterize the real-world burden of AD in Brazil, Mexico, and Argentina.</p><p><strong>Methods: </strong>MEASURE-AD enrolled patients (≥12-years old) with moderate to severe AD receiving or candidates for systemic therapy between December 2019-December 2020. Patient characteristics, treatments, and outcomes were recorded during one office visit. Primary outcome measures included worst itch/past 24hours (Worst Pruritus Numerical Rating Scale [WP-NRS]), quality of life (QoL, Dermatology Life Quality Index [DLQI] and Children's DLQI [CDLQI]).</p><p><strong>Results: </strong>Of 180 patients (adults, n=157; adolescents, n=23), 52.2% were male, the mean (SD) age was 33.8 (17.0) years, and all were receiving AD treatment (65.6% systemic therapy). Severe pruritus (WP-NRS ≥ 7) was reported by 54.4% (adults, 57.3%; adolescents, 34.8%). A very/extremely large effect on QoL (DLQI/CDLQI≥11) was reported among 50.0% of patients ≥ 16 years old and 42.9% of patients 12-15 years old. The mean Eczema Area Severity Index (EASI) was 17.0 (adults, 17.7; adolescents, 12.4); 3.9% of patients had clear skin (EASI 0) and 26.7% had severe AD (EASI 23-72). Over the previous 6 months, 0, 1-2, 3-4, 5-6, and > 6 flares were reported by 8.3%, 27.2%, 31.1%, 11.7%, and 15.6% of patients, respectively. On average, flares lasted 15.2 days (adults, 15.9 days; adolescents, 11.1 days).</p><p><strong>Study limitations: </strong>Patient self-reported information and recall during one office visit.</p><p><strong>Conclusions: </strong>Despite treatment, disease severity and impact on QoL were high, suggesting that AD is not adequately controlled in all patients, highlighting a considerable unmet need for effective treatments to reduce AD burden.</p>","PeriodicalId":7787,"journal":{"name":"Anais brasileiros de dermatologia","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143673072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"New insights into pyroptosis in pemphigus: from cellular structure to therapeutic targeting.","authors":"Jiazhen Chen, Zezhi He, Xiangnong Dai, Sifan Lin, Jiahui Liu, Xingdong Ye","doi":"10.1016/j.abd.2024.07.015","DOIUrl":"https://doi.org/10.1016/j.abd.2024.07.015","url":null,"abstract":"<p><strong>Background: </strong>Pemphigus is an autoimmune blistering disease where autoantibodies target desmoglein (Dsg) antigens on keratinocytes, triggering the p38 MAPK pathway, Dsg internalization, desmosomal dissolution, and keratinocyte apoptosis, are essential for blister formation. Recent research indicates keratinocyte pyroptosis may exacerbate acantholysis and delay wound healing. Current treatments, including corticosteroids and immunosuppressants, are effective but have significant side effects, such as prolonged wound healing and increased infection risk. Understanding these inflammatory processes is crucial for developing effective treatments for pemphigus.</p><p><strong>Methods: </strong>The authors conducted a comprehensive review of the literature, analyzing recent findings regarding the upregulation of pyroptosis-related proteins in pemphigus.</p><p><strong>Results: </strong>The present findings highlight a significant upregulation of pyroptosis-related proteins, which play a crucial role in the inflammatory response and blister formation characteristic of pemphigus. Key proteins such as cytokines IL-1β, IL-18, High Mobility Group Box-1 (HMGB1), and Parkin, along with NOD-like receptors and P2×7 receptors, were identified as pivotal in facilitating pyroptosis. The study also discusses potential therapeutic approaches targeting these proteins to modulate the disease pathway effectively.</p><p><strong>Study limitations: </strong>This study aimed to investigate the role of pyroptosis in the pathogenesis of pemphigus, focusing on its potential as a novel therapeutic target.</p><p><strong>Conclusions: </strong>Pyroptosis significantly contributes to the pathogenesis of pemphigus and presents a promising target for therapy. Targeting specific molecules involved in the pyroptosis pathway offers the potential for developing more precise and less toxic treatments, allowing the shift from traditional therapies towards targeted therapeutic strategies.</p>","PeriodicalId":7787,"journal":{"name":"Anais brasileiros de dermatologia","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143655927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Serum levels of vitamin D in people with albinism from Brazil.","authors":"Carolina Reato Marçon, Lilian Lemos Costa, Maria Paula Ribeiro Mazzon, Nathalia Terumi Kawakami, Camila Cardoso Paes Carvalho","doi":"10.1016/j.abd.2024.10.003","DOIUrl":"https://doi.org/10.1016/j.abd.2024.10.003","url":null,"abstract":"","PeriodicalId":7787,"journal":{"name":"Anais brasileiros de dermatologia","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143655928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Anais Brasileiros de Dermatologia: who wrote this century-old history?","authors":"Helena Cargnelutti Grimaldi, Sandro da Silva Camargo","doi":"10.1016/j.abd.2025.02.001","DOIUrl":"https://doi.org/10.1016/j.abd.2025.02.001","url":null,"abstract":"<p><p>The Anais Brasileiros de Dermatologia (ABD), an official publication of the Brazilian Society of Dermatology, has been published since 1925. ABD is considered the most influential dermatological journal in Latin America. By 2025, the journal will mark a significant milestone, celebrating a century of history. Over this time, it has published 99 volumes and 6,299 contributions from more than 10,800 authors. To analyze the trajectory of the journal, this study employs an applied research approach characterized by descriptive objectives and a quantitative nature. This research was based on a documentary procedure that encompassed all contributions already published in the journal. The main goal of the work was to identify the most prominent authors who have contributed to the journal and to map the largest co-authorship communities. The authors hope that this research serves as a formal recognition of the researchers who have written the history of the ABD.</p>","PeriodicalId":7787,"journal":{"name":"Anais brasileiros de dermatologia","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143655926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Treating Parry-Romberg syndrome with hyaluronic acid: insights after 2.5 years of successive treatments.","authors":"Roberta Vasconcelos-Berg, Barbara Varella Maire, Alexander A Navarini","doi":"10.1016/j.abd.2024.08.007","DOIUrl":"https://doi.org/10.1016/j.abd.2024.08.007","url":null,"abstract":"","PeriodicalId":7787,"journal":{"name":"Anais brasileiros de dermatologia","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143630034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Immunotherapy-induced psoriasis successfully treated with Guselkumab in a patient with metastatic gastric cancer.","authors":"Denis Miyashiro, Thiago William Carnier Jorge, André Luís da Silva Hirayama, José Antonio Sanches","doi":"10.1016/j.abd.2024.08.009","DOIUrl":"https://doi.org/10.1016/j.abd.2024.08.009","url":null,"abstract":"","PeriodicalId":7787,"journal":{"name":"Anais brasileiros de dermatologia","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143630031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}